Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol

• Үндсэн зохиолчид: Amaranto Suárez-Mattos (Зохиогч), Federico Arroyave (Зохиогч), Ana M. Infante (Зохиогч), Carlos Narváez (Зохиогч), Camilo Soto (Зохиогч), Luis Gómez (Зохиогч), Javier Amaya-Nieto (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Permanyer, 2022-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: High-grade osteosarcoma is the most common malignant bone tumor in children and adolescents. This study aimed to evaluate the histologic response to neoadjuvant chemotherapy and overall and event-free survival rates in patients < 21 years of age with a diagnosis of conventional osteos...